Immune to Cancer: The CRI Blog
-
Liver Cancer Awareness Month: 2021 Immunotherapy Research Updates
This October for Liver Cancer Awareness Month, let’s delve into new treatments, research insights, and how we…
-
Liver Cancer Awareness Month: 2019 Immunotherapy Research Update
For Liver Cancer Awareness Month, we round up the latest news and research from the people changing…
-
How Immunotherapy Is Making an Impact in Liver Cancer
We spoke with Bruno Sangro, MD, PhD, about the current treatment landscape for patients with liver cancer,…
-
FDA Approves Pembrolizumab Immunotherapy for Advanced Liver Cancer
Patients with advanced hepatocellular carcinoma (HCC), the most common form of liver cancer, can now receive PD-1…
-
Checkpoint Immunotherapy Approved for Patients with Stomach, Gastroesophageal, and Liver Cancer
Previously treated patients with these cancer types can now receive anti-PD-1 immunotherapy; nivolumab for HCC and pembrolizumab…